Clinical Trial Update: HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease [Phase 2]

View source ↗

Summary

This update notes a Phase 2 trial evaluating HER3-DXd in metastatic breast cancer and advanced non-small cell lung cancer (including brain metastases and leptom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• HER3-DXd

Snippet

Sponsor: MedSIR | Conditions: Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING